Global Clinical Operations Program Director (Gcopd)
Current• Led global cross functional teams in the planning and delivery of major global submission(s): creation and development of project and risk plans, monitoring of progress and issue resolution; establishing reviewer matrices; resource decisions; regulatory defense; regulatory inspection readiness preparation• Led global cross-functional team in the planning and delivery of the emergency use application (EUA) and conditional marketing application (CMA) for a Covid long acting monoclonal antibody • Led development, baselining, and maintenance of realistic & appropriate submission, project, and study plans (including timings, cost, and budget) for various programs. • Planned & facilitated Clinical Project Team (CPT) meetings and reported to the Global Project Team (GPT) and other senior stakeholders on an as-needed basis. Lead development of CPT objectives.• Provided extensive budget, FTE, and planning information to the GPVP in support of partnering discussions being held in Europe for the Movantik project.• Led planning, and strategy for extensive global at-home nursing support and sample shipment for the a major Ph III COPD study.• Led the development of clinical operations aspects of life cycle management (LCM) indications• Served as the Director Clinical Development (DCD) for the established neurosciences portfolio including all periodic safety reporting, addenda to clinical overviews, NDA annual reports, and license to operate renewals.• Provided product knowledge and expertise to the process of contracting out clinical studies through the SCOUT model and served as the single point of contact for CRO partners. • Developed model for the GCOPD, the global medical communications lead, and the regulatory project manager to work together in submission management and regulatory defense.• Created and developed a clinical guidance document, a process flow diagram, and a generic project plan for teams to use in planning the 4-Month Safety Update (4MSU).